We are grateful to partner with and support patient advocacy groups and programs that are aligned with our focus to improve the needs of people with neurological conditions.
Currently, we are raising seed funding (3 million) so we can complete our IND enable studies.
To learn more, please contact us.
Progenicyte Therapeutics, Inc.
Copyright © 2023 Progenicyte Therapeutics, Inc. - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.